These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2412058)

  • 41. Involvement of nitric oxide in fading of 5-hydroxytryptamine-induced vasocontraction in rat isolated vena portae smooth muscle.
    Datté JY; Offoumou MA
    J Pharm Pharm Sci; 2004 Jan; 7(1):1-7. PubMed ID: 15144728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Presence of vasoconstrictor 5HT1-like receptors revealed by precontraction of rabbit isolated mesenteric artery.
    Choppin A; O'Connor SE
    Br J Pharmacol; 1995 Jan; 114(2):309-14. PubMed ID: 7881730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potentiation of responses to sympathetic nerve stimulation and vasoconstrictor agents by SK&F 103829 in the feline mesenteric circulation.
    Taylor EM; Kaumann AJ
    Br J Pharmacol; 1994 Jan; 111(1):264-70. PubMed ID: 8012704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Typical and atypical antipsychotic drugs are potent antagonists of the relaxant 5-hydroxytryptamine receptor in the smooth muscle of canine coronary artery.
    Terrón JA
    Proc West Pharmacol Soc; 1996; 39():23-5. PubMed ID: 8895957
    [No Abstract]   [Full Text] [Related]  

  • 45. Mediation by 5_hydroxytryptamine of the femoral vasoconstriction induced by acid challenge of the rat gastric mucosa.
    Wachter CH; Heinemann A; Donnerer J; Pabst MA; Holzer P
    J Physiol; 1998 Jun; 509 ( Pt 2)(Pt 2):541-50. PubMed ID: 9575302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of serotonin-amplified human platelet aggregation by ketanserin, ritanserin, and the ergoline 5HT2 receptor antagonists-LY53857, sergolexole, and LY237733.
    McBride PA; Mann JJ; Nimchinsky E; Cohen ML
    Life Sci; 1990; 47(23):2089-95. PubMed ID: 2125095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insurmountable antagonism of AT-1015, a 5-HT2 antagonist, on serotonin-induced endothelium-dependent relaxation in porcine coronary artery.
    Rashid M; Nakazawa M; Nagatomo T
    J Pharm Pharmacol; 2003 Jun; 55(6):827-32. PubMed ID: 12841944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of ketanserin on the hyperreactivity of platelets to 5-hydroxytryptamine in patients with cardiovascular diseases.
    De Cree J; Leempoels J; Demoen B; Roels V; Verhaegen H
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S26-8. PubMed ID: 2412051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolongation of rat tail bleeding time by ketanserin: mechanisms of action.
    Buczko W; Gambino MC; De Gaetano G
    Eur J Pharmacol; 1984 Aug; 103(3-4):261-8. PubMed ID: 6237923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vasoactive effects of serotonin on proximal coronary arteries in awake dogs.
    Chu A; Cobb FR
    Circ Res; 1987 Nov; 61(5 Pt 2):II81-7. PubMed ID: 3664987
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced vasoconstrictor responses in renal and femoral arteries of the golden hamster during hibernation.
    Karoon P; Knight G; Burnstock G
    J Physiol; 1998 Nov; 512 ( Pt 3)(Pt 3):927-38. PubMed ID: 9769433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vascular serotonin receptors. Correlation with 5-HT1 and 5-HT2 binding sites.
    Peroutka SJ
    Biochem Pharmacol; 1984 Aug; 33(15):2349-53. PubMed ID: 6380502
    [No Abstract]   [Full Text] [Related]  

  • 53. Signalling pathways activated by 5-HT(1B)/5-HT(1D) receptors in native smooth muscle and primary cultures of rabbit renal artery smooth muscle cells.
    Hinton JM; Hill P; Jeremy J; Garland C
    J Vasc Res; 2000; 37(6):457-68. PubMed ID: 11146399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Local hemodynamic effects of serotonin and ketanserin in healthy subjects: studies in the forearm.
    Blauw GJ; van Brummelen P; Bruning T; van Zwieten PA
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S41-3. PubMed ID: 2459513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Augmented responses to 5-HT2-receptor-mediated vasoconstrictions in atherosclerotic rabbit common carotid arteries.
    Fujiwara T; Chiba S
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):503-10. PubMed ID: 8583795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade.
    Cohen RA
    J Pharmacol Exp Ther; 1986 May; 237(2):548-52. PubMed ID: 2939235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AHR-16303B, a novel antagonist of 5-HT2 receptors and voltage-sensitive calcium channels.
    Barrett RJ; Appell KC; Kilpatrick BF; Proakis AG; Nolan JC; Walsh DA
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):41-53. PubMed ID: 1708055
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological analysis of 5-HT-induced vasoconstriction in isolated, perfused dog skeletal muscle arteries.
    Sinanović O; Chiba S
    Eur J Pharmacol; 1987 Nov; 143(3):353-60. PubMed ID: 2891553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The acute effects of dexfenfluramine on human and porcine pulmonary vascular tone and resistance.
    Higenbottam T; Marriott H; Cremona G; Laude E; Bee D
    Chest; 1999 Oct; 116(4):921-30. PubMed ID: 10531154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cardiovascular pharmacology of serotonin and its antagonists].
    Van Nueten JM
    Rev Med Liege; 1988 Mar; 43 Suppl 1():22-30. PubMed ID: 3287545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.